Fact CheckerSign in

NCT05392491Completed

Brazilian Coronary ARtery Disease

The Brazilian Coronary Disease Cohort

Source: ClinicalTrials.gov · Last updated 4 May 2025

Brief summary (registry, in English)

Although coronary artery disease may have a stable chronic clinical course, it is known that this reality does not apply to atherosclerotic plaques, they can grow, complicate, stabilize and again start new cycles of growth/destabilization/stabilization or quiescence in the presence or absence of symptoms. While in obstructive coronary lesions there are well-founded guidelines based on multiple clinical studies, in relation to investigation and treatment; on the other hand, in non-obstructive lesions, there are no such guidelines. There are gaps in the knowledge about the prognostic implications of minor injuries and the occurrence of events. This study seeks precisely to fill these knowledge gaps. Of particular relevance are the large number of patients (approximately 10,000 patients) and the long clinical follow-up, that is, in eight years.

Status (registry)
Completed
Study type
Observational
Enrollment
4004 (actual)
First submitted
17 May 2022
Start date
1 Jun 2022
Primary completion date
1 May 2024
Lead sponsor
University of Sao Paulo General Hospital
NCT number
NCT05392491

What you commit to

  • Study type: Observational
  • Participants enrolled: 4004
  • From 1 Jun 2022 to the primary completion date, 1 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous history of acute coronary syndrome (infarction and unstable angina);
  • Revascularization interventions (surgical or percutaneous);

Other illness

  • Valvular heart disease;
  • Diseases with a poor prognosis (expected survival of less than 8 years).

Age

  • Age under 18 years or over 80 years at the time of examination;

Other

  • Cardiomyopathies;

Who the study is looking for

  • Patients referred to Instituto do Coração (InCor HC, FM-USP) for invasive coronary angiography or angiotomography.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Instituto do Coração InCor, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo
Coordinator of this site? Confirm its status
São PauloBrazilUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.